Eurofins Scientific SE Stock
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 01:28:17 | |||
| 70.28 EUR | +1.12% |
|
70.13 | -0.21% |
| 06-30 | NFL Biosciences validates industrial-scale production of NFL-102 for smoking cessation |  |
| 06-24 | Eurofins Scientific SE acquired Weatherbys Scientific. | CI |
| Market Cap | 12.15B 13.9B 11.21B 10.33B 19.47B 1,338B 19.9B 134B 52.69B 655B 52.19B 51.05B 2,256B | P/E 2026 * |
24.1x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 15.59B 17.84B 14.38B 13.26B 24.99B 1,718B 25.54B 172B 67.62B 841B 66.98B 65.51B 2,896B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.89x |
| Free-Float |
58.35% | Yield 2026 * |
1.11% | Yield 2027 * | 1.29% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.12% | ||
| 1 week | +1.91% | ||
| Current month | +2.51% | ||
| 1 month | +12.38% | ||
| 3 months | +0.63% | ||
| 6 months | -2.28% | ||
| Current year | +12.63% |
| 1 week | 68.12 |  | 70.84 |
| 1 month | 61.44 | | 70.84 |
| Current year | 56.84 | | 74.32 |
| 1 year | 54.86 | | 74.32 |
| 3 years | 39.47 | | 74.32 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 29.82 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 01/01/1987 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 01/01/2015 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 01/01/1987 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 01/01/2015 |
Valérie Hanote
BRD | Director/Board Member | 60 | 01/01/1990 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/4/26 | Buy | 700 | 0.0004% | |||
| 19/4/26 | Fiscal year | Chief Financial Officer | 6,000 | 0.0033% | ||
| 19/4/26 | Sell | Executive/Senior Manager | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | +1.91% | +15.90% | +19.65% | 13.89B | |
| -1.29% | -3.11% | -0.39% | +4.92% | 49.7B | |
| +3.38% | -1.02% | +373.70% | +595.15% | 38.09B | |
| -1.56% | +4.69% | +7.70% | +58.02% | 35.29B | |
| -1.78% | -0.68% | +26.46% | -6.74% | 35.13B | |
| +0.06% | +1.56% | +4.41% | +27.42% | 27.22B | |
| +1.77% | -1.91% | - | - | 16.14B | |
| +0.31% | -0.17% | +68.35% | +117.21% | 15.36B | |
| +0.43% | +1.58% | +16.00% | -30.47% | 13.02B | |
| -0.08% | -3.01% | +1,271.69% | +649.69% | 11.76B | |
| Average | +0.19% | -0.78% | +198.20% | +159.43% | 25.56B | |
| Weighted average by Cap. | -0.05% | -0.74% | +133.54% | +145.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.6B 8.7B 7.01B 6.46B 12.18B 837B 12.45B 83.82B 32.97B 410B 32.66B 31.94B 1,412B | 8.07B 9.24B 7.45B 6.87B 12.94B 890B 13.23B 89.05B 35.03B 436B 34.7B 33.94B 1,500B |
| Net income | 517M 591M 477M 439M 828M 56.94B 847M 5.7B 2.24B 27.88B 2.22B 2.17B 95.99B | 676M 774M 624M 575M 1.08B 74.51B 1.11B 7.46B 2.93B 36.49B 2.91B 2.84B 126B |
| Net Debt | 3.44B 3.94B 3.18B 2.93B 5.52B 379B 5.64B 37.96B 14.93B 186B 14.79B 14.47B 639B | 3.08B 3.53B 2.85B 2.62B 4.95B 340B 5.05B 34.02B 13.38B 166B 13.26B 12.96B 573B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | €70.28 | +1.12% | 272,834 |
| 16/07/26 | €69.50 | +0.29% | 169,938 |
| 15/07/26 | €69.30 | +0.43% | 273,072 |
| 14/07/26 | €69.00 | -0.72% | 225,880 |
| 13/07/26 | €69.50 | +0.78% | 151,866 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
